Can pridopidine slow ALS? major trial underway
Disease control
Recruiting now
This phase 3 trial is testing whether the drug pridopidine can slow the progression of amyotrophic lateral sclerosis (ALS) in 500 adults. Participants will take either pridopidine or a placebo daily for 48 weeks, followed by an open-label extension where everyone receives the dru…
Phase: PHASE3 • Sponsor: Prilenia • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC